The "14th Five-Year Plan" eye health plan clearly states that "the level of eye diseases such as orbital diseases will be further improved". In order to respond to this call, further promote the healthy and standardized development of oculoplastic surgery and thyroid-related eye diseases, and strengthen high-level academic exchanges in oculoplastic orbital diseases, the "2023 National Continuing Medical Education Program Ophthalmology Practical Surgery Techniques and New Progress Workshop Fourth Session and the 2nd National Thyroid Related Eye Disease Expert Forum" sponsored by the Ophthalmology Professional Committee of the China Association of Non-public Medical Institutions and undertaken by the Oculoplastic Group of Aier Eye Hospital Group and Changsha Aier Eye Hospital It was held in Changsha, Hunan Province from December 23rd to 24th. It aims to provide a high-standard and high-level academic feast for ophthalmologists in the province and the whole country.
In this conference, more than 30 experts in the field of orbital disease oculoplastic surgery from Zhongshan Eye Center of Sun Yat-sen University, Eye and Otolaryngology Hospital Affiliated to Fudan University, Shanghai Ninth People's Hospital and Aier Eye Hospital Group will gather in Changsha with more than 100 scholars and young backbone physicians in the field of ophthalmology in the province to exchange and communicate on clinical diagnosis, cutting-edge technology and difficult surgical operations in the direction of eyelid diseases, eye cosmetic plastic surgery and thyroid-related eye diseases.
For patients, the disease** is just as important as cosmetic surgery. Oculoplastic surgery, which is closely related to orbital disease, is not only for medical aesthetics, but also for repairing the appearance damage caused by eye diseases and rebuilding patients' confidence in life. Professor Qian Jiang, Professor Lu Rong, Professor Jia Renbing, Professor Yuan Hongfeng and other industry leaders will share and exchange ideas on the topics of "Recompression Surgery for Thyroid Eye Disease", "Analysis of Elements of Transnasal Endoscopic Orbital Decompression Surgery for Thyroid Eye Disease", and "Several Issues of TAO Surgery".
At the same time, the conference added practical training on ocular microplastic injection, and explained the new injection concept in detail from facial muscle anatomy, blepharospasm botulinum toxin injection method, and wrinkle removal injection method. The team of teaching experts represented by Professor Sun Fengyuan, Professor Qianqian, Director Yan Huifang and Director Zhou Yandan of Aier Eye Hospital Group will carry out theoretical teaching from the direction of oculoplastic anatomy, common pathological oculoplastic diagnosis and treatment, and periorbital rejuvenation beauty, so that students can master the theoretical knowledge from periorbital diseases to ocular beauty. In addition, while enjoying the theoretical feast, the young doctors participated in the conference carried out the practical operation of microplastic surgery injection under the guidance of experts to improve their practical ability.
With the increasing research on orbital disease, diagnosis and methods are also changing with each passing day. In recent years, Aier Ophthalmology has also launched the "Thyroid Related Eye Disease Clinic", which aims to provide systematic, standardized, personalized and convenient diagnosis and treatment for patients suffering from thyroid-related eye diseases through specialized treatment. At the same time, in order to allow patients with eye tumors and orbital diseases in financial difficulties to receive timely assistance and assistance, Aier Ophthalmology has vigorously carried out public welfare assistance and established the "Orbital Care Bright" Eye Tumor Orbital Disease Public Welfare Assistance**, which has rescued 57 patients in difficulty so far, covering Sichuan, Chongqing, Guizhou, Fujian, Hubei, Shandong, Shanxi and other parts of the country, helping the high-quality development of eye health.